BBIO icon

BridgeBio Pharma

250 hedge funds and large institutions have $4.43B invested in BridgeBio Pharma in 2024 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 106 increasing their positions, 73 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

0.38% more ownership

Funds ownership: 93.11%93.49% (+0.38%)

14% less funds holding in top 10

Funds holding in top 10: 1412 (-2)

18% less capital invested

Capital invested by funds: $5.42B → $4.43B (-$989M)

Holders
250
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
12
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$306M
Puts
$85.9M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
151
$613K
152
$600K
153
$590K
154
$557K
155
$543K
156
$532K
157
$501K
158
$487K
159
$483K
160
$473K
161
$423K
162
$418K
163
$409K
164
$394K
165
$385K
166
$380K
167
$380K
168
$377K
169
$367K
170
$360K
171
$353K
172
$349K
173
$342K
174
$337K
175
$337K